Therapeutic drug monitoring of itraconazole and the relevance of pharmacokinetic interactions
Open Access
- 1 December 2006
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 12 (s7) , 97-106
- https://doi.org/10.1111/j.1469-0691.2006.01611.x
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- The place for itraconazole in treatmentJournal of Antimicrobial Chemotherapy, 2005
- Drug Metabolism and Variability among Patients in Drug ResponseNew England Journal of Medicine, 2005
- In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamicsJournal of Clinical Pharmacy & Therapeutics, 2001
- ANTIMICROBIAL PHARMACODYNAMICSMedical Clinics of North America, 2000
- Inhibition and Induction of Cytochrome P450 and the Clinical ImplicationsClinical Pharmacokinetics, 1998
- Clinical Pharmacokinetics in the 21st CenturyClinical Pharmacokinetics, 1998
- Omeprazole does not affect measured CYP3A4 activity using the erythromycin breath test [letter]British Journal of Clinical Pharmacology, 1995
- The erythromycin breath test predicts the clearance of midazolam*Clinical Pharmacology & Therapeutics, 1995
- Comparison of urinary 6-β-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activityClinical Pharmacology & Therapeutics, 1992